Table of Contents Author Guidelines Submit a Manuscript
International Journal of Polymer Science
Volume 2015, Article ID 782653, 11 pages
http://dx.doi.org/10.1155/2015/782653
Review Article

Polymers for Cardiovascular Stent Coatings

1Ernst-Moritz-Arndt University, Clinic for Internal Medicine B, Ferdinand-Sauerbruch-Straße, 17475 Greifswald, Germany
2DZHK (German Centre for Cardiovascular Research), Fleischmannstrasse 42-44, 17489 Greifswald, Germany

Received 23 December 2014; Revised 20 April 2015; Accepted 20 April 2015

Academic Editor: Crispin Dass

Copyright © 2015 Anne Strohbach and Raila Busch. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Krenning, M. J. A. van Luyn, and M. C. Harmsen, “Endothelial progenitor cell-based neovascularization: implications for therapy,” Trends in Molecular Medicine, vol. 15, no. 4, pp. 180–189, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Liu, S. Liu, K. Zhang, J. Chen, and N. Huang, “Endothelialization of implanted cardiovascular biomaterial surfaces: the development from in vitro to in vivo,” Journal of Biomedical Materials Research Part A, vol. 102, no. 10, pp. 3754–3772, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Rogers, D. Y. Tseng, J. C. Squire, and E. R. Edelman, “Balloon-artery interactions during stent placement: a finite element analysis approach to pressure, compliance, and stent design as contributors to vascular injury,” Circulation Research, vol. 84, no. 4, pp. 378–383, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Wenaweser, C. Rey, F. R. Eberli et al., “Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome,” European Heart Journal, vol. 26, no. 12, pp. 1180–1187, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Windecker and B. Meier, “Late coronary stent thrombosis,” Circulation, vol. 116, no. 17, pp. 1952–1965, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. T. C. Woods and A. R. Marks, “Drug-eluting stents,” Annual Review of Medicine, vol. 55, pp. 169–178, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Farb, A. P. Burke, F. D. Kolodgie, and R. Virmani, “Pathological mechanisms of fatal late coronary stent thrombosis in humans,” Circulation, vol. 108, no. 14, pp. 1701–1706, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Joner, A. V. Finn, A. Farb et al., “Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk,” Journal of the American College of Cardiology, vol. 48, no. 1, pp. 193–202, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Lanzer, K. Sternberg, K.-P. Schmitz, F. Kolodgie, G. Nakazawa, and R. Virmani, “Drug-eluting coronary stent very late thrombosis revisited,” Herz, vol. 33, no. 5, pp. 334–342, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. R. A. Byrne, J. Mehilli, R. Iijima et al., “A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents,” European Heart Journal, vol. 30, no. 8, pp. 923–931, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Virmani, F. D. Kolodgie, and A. Farb, “Drug-eluting stents: are they really safe?” The American Heart Hospital Journal, vol. 2, no. 2, pp. 85–88, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. J. R. Nebeker, R. Virmani, C. L. Bennett et al., “Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project,” Journal of the American College of Cardiology, vol. 47, no. 1, pp. 175–181, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Garg and P. W. Serruys, “Coronary stents: looking forward,” Journal of the American College of Cardiology, vol. 56, no. 10, pp. S43–S78, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. C. M. Campos, T. Muramatsu, J. Iqbal et al., “Bioresorbable drug-eluting magnesium-alloy scaffold for treatment of coronary artery disease,” International Journal of Molecular Sciences, vol. 14, no. 12, pp. 24492–24500, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Waksman, “Biodegradable stents: they do their job and disappear,” The Journal of Invasive Cardiology, vol. 18, no. 2, pp. 70–74, 2006. View at Google Scholar · View at Scopus
  16. S. Brugaletta, H. M. Garcia-Garcia, Y. Onuma, and P. W. Serruys, “Everolimus-eluting ABSORB bioresorbable vascular scaffold: present and future perspectives,” Expert Review of Medical Devices, vol. 9, no. 4, pp. 327–338, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. P. W. Serruys, H. M. Garcia-Garcia, and Y. Onuma, “From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?” European Heart Journal, vol. 33, no. 1, pp. 16–25, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. J. P. Theron, J. H. Knoetze, R. D. Sanderson et al., “Modification, crosslinking and reactive electrospinning of a thermoplastic medical polyurethane for vascular graft applications,” Acta Biomaterialia, vol. 6, no. 7, pp. 2434–2447, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. Z.-J. Hu, Z.-L. Li, L.-Y. Hu et al., “The in vivo performance of small-caliber nanofibrous polyurethane vascular grafts,” BMC Cardiovascular Disorders, vol. 12, article 115, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. W. He, Z. Hu, A. Xu et al., “The preparation and performance of a new polyurethane vascular prosthesis,” Cell Biochemistry and Biophysics, vol. 66, no. 3, pp. 855–866, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Han, S. Farah, A. J. Domb, and P. I. Lelkes, “Electrospun rapamycin-eluting polyurethane fibers for vascular grafts,” Pharmaceutical Research, vol. 30, no. 7, pp. 1735–1748, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. C. K. S. Pillai and C. P. Sharma, “Review paper: absorbable polymeric surgical sutures: chemistry, production, properties, biodegradability, and performance,” Journal of Biomaterials Applications, vol. 25, no. 4, pp. 291–366, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Diban, S. Haimi, L. Bolhuis-Versteeg et al., “Hollow fibers of poly(lactide-co-glycolide) and poly(ϵ-caprolactone) blends for vascular tissue engineering applications,” Acta Biomaterialia, vol. 9, no. 5, pp. 6450–6458, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Yi, H. Wu, and G.-L. Jia, “Formulation and characterization of poly (D,L-lactide-co-glycolide) nanoparticle containing vascular endothelial growth factor for gene delivery,” Journal of Clinical Pharmacy and Therapeutics, vol. 31, no. 1, pp. 43–48, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. S. A. Yehia, A. H. Elshafeey, and I. Elsayed, “A novel injectable in situ forming poly-DL-lactide and DL-lactide/glycolide implant containing lipospheres for controlled drug delivery,” Journal of Liposome Research, vol. 22, no. 2, Article ID 631141, pp. 128–138, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Amjadi, M. Rabiee, M. S. Hosseini, and M. Mozafari, “Synthesis and characterization of doxorubicin-loaded poly(lactide-co- glycolide) nanoparticles as a sustained-release anticancer drug delivery system,” Applied Biochemistry and Biotechnology, vol. 168, no. 6, pp. 1434–1447, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. M. van Alst, M. J. D. Eenink, M.-A. B. Kruft, and R. Van Tuil, “ABC's of bioabsorption: application of lactide based polymers in fully resorbable cardiovascular stents,” EuroIntervention, vol. 5, pp. F23–F27, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Onuma, D. Dudek, L. Thuesen et al., “Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the absorb cohort a trial,” JACC: Cardiovascular Interventions, vol. 6, no. 10, pp. 999–1009, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. C. V. Bourantas, M. I. Papafaklis, A. Kotsia et al., “Effect of the endothelial shear stress patterns on neointimal proliferation following drug-eluting bioresorbable vascular scaffold implantation: an optical coherence tomography study,” JACC: Cardiovascular Interventions, vol. 7, no. 3, pp. 315–324, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. A. L. Sisson, M. Schroeter, A. Lendlein, A. Lendlein, and A. Sisson, Eds., Handbook of Biodegradable Polymers, Wiley-VCH, 2011.
  31. H.-H. Wang, X.-R. Zhou, Q. Liu, and G.-Q. Chen, “Biosynthesis of polyhydroxyalkanoate homopolymers by Pseudomonas putida,” Applied Microbiology and Biotechnology, vol. 89, no. 5, pp. 1497–1507, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Hu, A.-L. Chung, L.-P. Wu et al., “Biosynthesis and characterization of polyhydroxyalkanoate block copolymer P3HB-b-P4HB,” Biomacromolecules, vol. 12, no. 9, pp. 3166–3173, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. S. F. Williams, S. Rizk, and D. P. Martin, “Poly-4-hydroxybutyrate (P4HB): a new generation of resorbable medical devices for tissue repair and regeneration,” Biomedizinische Technik, vol. 58, no. 5, pp. 439–452, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. W. J. van der Giessen, A. M. Lincoff, R. S. Schwartz et al., “Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries,” Circulation, vol. 94, no. 7, pp. 1690–1697, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Hezi-Yamit, C. Sullivan, J. Wong et al., “Impact of polymer hydrophilicity on biocompatibility: implication for DES polymer design,” Journal of Biomedical Materials Research Part A, vol. 90, no. 1, pp. 133–141, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Ceonzo, A. Gaynor, L. Shaffer, K. Kojima, C. A. Vacanti, and G. L. Stahl, “Polyglycolic acid-induced inflammation: role of hydrolysis and resulting complement activation,” Tissue Engineering, vol. 12, no. 2, pp. 301–308, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Commandeur, H. M. M. van Beusekom, and W. J. van der Giessen, “Polymers, drug release, and drug-eluting stents,” Journal of Interventional Cardiology, vol. 19, no. 6, pp. 500–506, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. P. W. Serruys and N. Kukreja, “Late stent thrombosis in drug-eluting stents: return of the ‘VB syndrome’,” Nature Clinical Practice Cardiovascular Medicine, vol. 3, no. 12, article 637, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Grube, U. Gerckens, R. Müller, and L. Büllesfeld, “Drug eluting stents: initial experiences,” Zeitschrift für Kardiologie, vol. 91, no. 3, pp. 44–48, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Kukreja, Y. Onuma, J. Daemen, and P. W. Serruys, “The future of drug-eluting stents,” Pharmacological Research, vol. 57, no. 3, pp. 171–180, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. A. T. L. Ong and P. W. Serruys, “Technology insight: an overview of research in drug-eluting stents,” Nature Clinical Practice Cardiovascular Medicine, vol. 2, no. 12, pp. 647–658, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. M. J. Patel, S. S. Patel, N. S. Patel, and N. M. Patel, “Current status and future prospects of drug eluting stents for restenosis,” Acta Pharmaceutica, vol. 62, no. 4, pp. 473–496, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Sun, Y. Zheng, T. Yin, C. Tang, Q. Yu, and G. Wang, “Coronary drug-eluting stents: from design optimization to newer strategies,” Journal of Biomedical Materials Research Part A, vol. 102, no. 5, pp. 1625–1640, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. E. P. Navarese, F. Castriota, G. M. Sangiorgi, and A. Cremonesi, “From the abluminal biodegradable polymer stent to the polymer free stent. Clinical evidence,” Minerva Cardioangiologica, vol. 61, no. 2, pp. 243–254, 2013. View at Google Scholar · View at Scopus
  45. E. P. Navarese, M. Kowalewski, B. Cortese et al., “Short and long-term safety and efficacy of polymer-free vs. durable polymer drug-eluting stents. A comprehensive meta-analysis of randomized trials including 6178 patients,” Atherosclerosis, vol. 233, no. 1, pp. 224–231, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Stiermaier, A. Heinz, D. Schloma et al., “Five-year clinical follow-up of a randomized comparison of a polymer-free sirolimus-eluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus (LIPSIA Yukon trial),” Catheterization and Cardiovascular Interventions, vol. 83, no. 3, pp. 418–424, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. P. W. Serruys, S. Silber, S. Garg et al., “Comparison of zotarolimus-eluting and everolimus-eluting coronary stents,” The New England Journal of Medicine, vol. 363, no. 2, pp. 136–146, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Silber, S. Windecker, P. Vranckx, and P. W. Serruys, “Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial,” The Lancet, vol. 377, no. 9773, pp. 1241–1247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. J. Youn, J.-W. Lee, S. G. Ahn et al., “Study design and rationale of a multicenter, open-labeled, randomized controlled trial comparing three 2nd-generation drug-eluting stents in real-world practice (CHOICE trial),” American Heart Journal, vol. 166, no. 2, pp. 224–229, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Petersen, J. Hussner, T. Reske et al., “In vitro study of dual drug-eluting stents with locally focused sirolimus and atorvastatin release,” Journal of Materials Science: Materials in Medicine, vol. 24, no. 11, pp. 2589–2600, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Petersen, A. Strohbach, R. Busch, S. B. Felix, K.-P. Schmitz, and K. Sternberg, “Site-selective immobilization of anti-CD34 antibodies to poly(l -lactide) for endovascular implant surfaces,” Journal of Biomedical Materials Research, Part B: Applied Biomaterials, vol. 102, no. 2, pp. 345–355, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Colombo, J. Drzewiecki, A. Banning et al., “Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions,” Circulation, vol. 108, no. 7, pp. 788–794, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. G. W. Stone, S. G. Ellis, D. A. Cox et al., “A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease,” The New England Journal of Medicine, vol. 350, no. 3, pp. 221–231, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. I. T. Meredith, P. S. Teirstein, A. Bouchard et al., “Three-year results comparing platinum-chromium PROMUS element and cobalt-chromium XIENCE V everolimus-eluting stents in de novo coronary artery narrowing (from the PLATINUM trial),” The American Journal of Cardiology, vol. 113, no. 7, pp. 1117–1123, 2014. View at Publisher · View at Google Scholar
  55. K. Waseda, A. Miyazawa, J. Ako et al., “Intravascular ultrasound results from the endeavor iv trial: randomized comparison between zotarolimus- and paclitaxeleluting stents in patients with coronary artery disease,” JACC: Cardiovascular Interventions, vol. 2, no. 8, pp. 779–784, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. M. B. Leon, L. Mauri, J. J. Popma et al., “A randomized comparison of the endeavor zotarolimus-eluting stent versus the taxus paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the endeavor iv trial,” Journal of the American College of Cardiology, vol. 55, no. 6, pp. 543–554, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. T. Watanabe, M. Fujita, M. Awata et al., “Integrity of stent polymer layer after drug-eluting stent implantation: in vivo comparison of sirolimus-, paclitaxel-, zotarolimus- and everolimus-eluting stents,” Cardiovascular Intervention and Therapeutics, vol. 29, no. 1, pp. 4–10, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. Y. Onuma, N. Kukreja, N. Piazza et al., “The everolimus-eluting stent in real-world patients: 6-month follow-up of the x-search (xience v stent evaluated at rotterdam cardiac hospital) registry,” Journal of the American College of Cardiology, vol. 54, no. 3, pp. 269–276, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Verheye, P. Agostoni, K. D. Dawkins et al., “The genesis (randomized, multicenter study of the pimecrolimus-eluting and pimecrolimus/paclitaxel-eluting coronary stent system in patients with de novo lesions of the native coronary arteries) trial,” JACC: Cardiovascular Interventions, vol. 2, no. 3, pp. 205–214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Windecker, P. W. Serruys, S. Wandel et al., “Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial,” The Lancet, vol. 372, no. 9644, pp. 1163–1173, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. M. C. Ostojic, Z. Perisic, D. Sagic et al., “The pharmacokinetics of Biolimus A9 after elution from the BioMatrix II stent in patients with coronary artery disease: the Stealth PK Study,” European Journal of Clinical Pharmacology, vol. 67, no. 4, pp. 389–398, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. G. G. Stefanini, B. Kalesan, P. W. Serruys et al., “Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial,” The Lancet, vol. 378, no. 9807, pp. 1940–1948, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. E. Romagnoli, A. M. Leone, F. Burzotta et al., “Outcomes of the tacrolimus drug-eluting Janus stent: a prospective two-centre registry in high-risk patients,” Journal of Cardiovascular Medicine, vol. 9, no. 6, pp. 589–594, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. J. Iqbal, J. Gunn, and P. W. Serruys, “Coronary stents: historical development, current status and future directions,” British Medical Bulletin, vol. 106, no. 1, pp. 193–211, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. E. J. Smith, A. K. Jain, and M. T. Rothman, “New developments in coronary stent technology,” Journal of Interventional Cardiology, vol. 19, no. 6, pp. 493–499, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. H. Schühlen, A. Kastrati, J. Mehilli et al., “Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement,” American Heart Journal, vol. 147, no. 2, pp. 317–322, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. C. Chaabane, F. Otsuka, R. Virmani, and M.-L. Bochaton-Piallat, “Biological responses in stented arteries,” Cardiovascular Research, vol. 99, no. 2, pp. 353–363, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. R. Fattori and T. Piva, “Drug-eluting stents in vascular intervention,” The Lancet, vol. 361, no. 9353, pp. 247–249, 2003. View at Publisher · View at Google Scholar · View at Scopus
  69. H. M. Burt and W. L. Hunter, “Drug-eluting stents: a multidisciplinary success story,” Advanced Drug Delivery Reviews, vol. 58, no. 3, pp. 350–357, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. R. S. Schwartz, E. R. Edelman, A. Carter et al., “Drug-eluting stents in preclinical studies recommended evaluation from a consensus group,” Circulation, vol. 106, no. 14, pp. 1867–1873, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. F. Otsuka, A. V. Finn, S. K. Yazdani, M. Nakano, F. D. Kolodgie, and R. Virmani, “The importance of the endothelium in atherothrombosis and coronary stenting,” Nature Reviews Cardiology, vol. 9, no. 8, pp. 439–453, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. T. Tada and M. A. Reidy, “Endothelial regeneration. IX. Arterial injury followed by rapid endothelial repair induces smooth-muscle-cell proliferation but not intimal thickening,” American Journal of Pathology, vol. 129, no. 3, pp. 429–433, 1987. View at Google Scholar · View at Scopus
  73. F. N. G. Doornekamp, C. Borst, and M. J. Post, “The influence of lesion length on intimal hyperplasia after fogarty balloon injury in the rabbit carotid artery: role of endothelium,” Journal of Vascular Research, vol. 34, no. 4, pp. 260–266, 1997. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Gouverneur, B. van den Berg, M. Nieuwdorp, E. Stroes, and H. Vink, “Vasculoprotective properties of the endothelial glycocalyx: effects of fluid shear stress,” Journal of Internal Medicine, vol. 259, no. 4, pp. 393–400, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. T. Asahara, H. Masuda, T. Takahashi et al., “Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization,” Circulation Research, vol. 85, no. 3, pp. 221–228, 1999. View at Publisher · View at Google Scholar · View at Scopus
  76. M. Joner, G. Nakazawa, A. V. Finn et al., “Endothelial cell recovery between comparator polymer-based drug-eluting stents,” Journal of the American College of Cardiology, vol. 52, no. 5, pp. 333–342, 2008. View at Publisher · View at Google Scholar · View at Scopus
  77. D. F. Williams, “On the mechanisms of biocompatibility,” Biomaterials, vol. 29, no. 20, pp. 2941–2953, 2008. View at Publisher · View at Google Scholar · View at Scopus
  78. R. S. O'Connor, X. Hao, K. Shen et al., “Substrate rigidity regulates human T cell activation and proliferation,” Journal of Immunology, vol. 189, no. 3, pp. 1330–1339, 2012. View at Publisher · View at Google Scholar · View at Scopus
  79. R. Busch, A. Strohbach, S. Peterson, K. Sternberg, and S. Felix, “Parameters of endothelial function are dependent on polymeric surface material,” Biomedical Engineering/Biomedizinische Technik, 2013. View at Publisher · View at Google Scholar
  80. R. Busch, A. Strohbach, S. Rethfeldt et al., “New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets,” Acta Biomaterialia, vol. 10, no. 2, pp. 688–700, 2014. View at Publisher · View at Google Scholar · View at Scopus
  81. H. M. M. van Beusekom, D. M. Whelan, S. H. Hofma et al., “Long-term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries,” Journal of the American College of Cardiology, vol. 32, no. 4, pp. 1109–1117, 1998. View at Publisher · View at Google Scholar · View at Scopus
  82. P. M. Vanhoutte, “Endothelial dysfunction—the first step toward coronary arteriosclerosis,” Circulation Journal, vol. 73, no. 4, pp. 595–601, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. D. A. Duprez, “Arterial stiffness and endothelial function: key players in vascular health,” Hypertension, vol. 55, no. 3, pp. 612–613, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. J. A. Wood, N. M. Shah, C. T. McKee et al., “The role of substratum compliance of hydrogels on vascular endothelial cell behavior,” Biomaterials, vol. 32, no. 22, pp. 5056–5064, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. X. Peng, S. Haldar, S. Deshpande, K. Irani, and D. A. Kass, “Wall stiffness suppresses Akt/eNOS and cytoprotection in pulse-perfused endothelium,” Hypertension, vol. 41, no. 2, pp. 378–381, 2003. View at Publisher · View at Google Scholar · View at Scopus
  86. A. J. Engler, M. A. Griffin, S. Sen, C. G. Bönnemann, H. L. Sweeney, and D. E. Discher, “Myotubes differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff microenvironments,” Journal of Cell Biology, vol. 166, no. 6, pp. 877–887, 2004. View at Publisher · View at Google Scholar · View at Scopus
  87. F. Rehfeldt, A. J. Engler, A. Eckhardt, F. Ahmed, and D. E. Discher, “Cell responses to the mechanochemical microenvironment—implications for regenerative medicine and drug delivery,” Advanced Drug Delivery Reviews, vol. 59, no. 13, pp. 1329–1339, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. K. Kulangara, Y. Yang, J. Yang, and K. W. Leong, “Nanotopography as modulator of human mesenchymal stem cell function,” Biomaterials, vol. 33, no. 20, pp. 4998–5003, 2012. View at Publisher · View at Google Scholar · View at Scopus
  89. K. Kulangara, A. F. Adler, H. Wang et al., “The effect of substrate topography on direct reprogramming of fibroblasts to induced neurons,” Biomaterials, vol. 35, no. 20, pp. 5327–5336, 2014. View at Publisher · View at Google Scholar · View at Scopus
  90. Y. L. Jung and H. J. Donahue, “Cell sensing and response to micro- and nanostructured surfaces produced by chemical and topographic patterning,” Tissue Engineering, vol. 13, no. 8, pp. 1879–1891, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. D. M. Le, K. Kulangara, A. F. Adler, K. W. Leong, and V. S. Ashby, “Dynamic topographical control of mesenchymal stem cells by culture on responsive poly(ϵ-caprolactone) surfaces,” Advanced Materials, vol. 23, no. 29, pp. 3278–3283, 2011. View at Publisher · View at Google Scholar
  92. R. E. Gerszten, E. A. Garcia-Zepeda, Y.-C. Lim et al., “MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions,” Nature, vol. 398, no. 6729, pp. 718–725, 1999. View at Publisher · View at Google Scholar · View at Scopus
  93. F. G. P. Welt and C. Rogers, “Inflammation and restenosis in the stent era,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 11, pp. 1769–1776, 2002. View at Publisher · View at Google Scholar · View at Scopus
  94. H. C. Cohen, E. J. Joyce, and W. J. Kao, “Biomaterials selectively modulate interactions between human blood-derived polymorphonuclear leukocytes and monocytes,” The American Journal of Pathology, vol. 182, no. 6, pp. 2180–2190, 2013. View at Publisher · View at Google Scholar · View at Scopus
  95. A. P. Khandwekar, D. P. Patil, Y. Shouche, and M. Doble, “Surface engineering of polycaprolactone by biomacromolecules and their blood compatibility,” Journal of Biomaterials Applications, vol. 26, no. 2, pp. 227–252, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. H. M. Rinder, J. L. Bonan, C. S. Rinder, K. A. Ault, and B. R. Smith, “Dynamics of leukocyte-platelet adhesion in whole blood,” Blood, vol. 78, no. 7, pp. 1730–1737, 1991. View at Google Scholar · View at Scopus
  97. J. M. Anderson, A. Rodriguez, and D. T. Chang, “Foreign body reaction to biomaterials,” Seminars in Immunology, vol. 20, no. 2, pp. 86–100, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. W.-B. Tsai, J. M. Grunkemeier, C. D. McFarland, and T. A. Horbett, “Platelet adhesion to polystyrene-based surfaces preadsorbed with plasmas selectively depleted in fibrinogen, fibronectin, vitronectin, or von Willebrand's factor,” Journal of Biomedical Materials Research, vol. 60, no. 3, pp. 348–359, 2002. View at Publisher · View at Google Scholar · View at Scopus
  99. N. Swansons and A. Gershlick, “Glycoprotein (GP) IIb/IIIa receptor antagonist eluting stents,” in Local Drug Delivery for Coronary Artery Disease: Established and Emerging Applications, Taylor & Francis, 2005. View at Google Scholar
  100. H. Nygren, “Initial reactions of whole blood with hydrophilic and hydrophobic titanium surfaces,” Colloids and Surfaces B: Biointerfaces, vol. 6, no. 4-5, pp. 329–333, 1996. View at Publisher · View at Google Scholar · View at Scopus
  101. J. H. Lee and H. B. Lee, “Platelet adhesion onto wettability gradient surfaces in the absence and presence of plasma proteins,” Journal of Biomedical Materials Research, vol. 41, no. 2, pp. 304–311, 1998. View at Publisher · View at Google Scholar · View at Scopus
  102. R. K. Aggarwal, D. C. Ireland, M. A. Azrin, M. D. Ezekowitz, D. P. de Bono, and A. H. Gershlick, “Antithrombotic potential of polymer-coated stents eluting platelet glycoprotein IIb/IIIa receptor antibody,” Circulation, vol. 94, no. 12, pp. 3311–3317, 1996. View at Publisher · View at Google Scholar · View at Scopus
  103. H. Xu, K. T. Nguyen, E. S. Brilakis, J. Yang, E. Fuh, and S. Banerjee, “Enhanced endothelialization of a new stent polymer through surface enhancement and incorporation of growth factor-delivering microparticles,” Journal of Cardiovascular Translational Research, vol. 5, no. 4, pp. 519–527, 2012. View at Publisher · View at Google Scholar · View at Scopus
  104. L. Mao, L. Shen, J. Niu et al., “Nanophasic biodegradation enhances the durability and biocompatibility of magnesium alloys for the next-generation vascular stents,” Nanoscale, vol. 5, no. 20, pp. 9517–9522, 2013. View at Publisher · View at Google Scholar · View at Scopus
  105. M. Sgarioto, R. Adhikari, P. A. Gunatillake et al., “Properties and in vitro evaluation of high modulus biodegradable polyurethanes for applications in cardiovascular stents,” Journal of Biomedical Materials Research, Part B: Applied Biomaterials, vol. 102, no. 8, pp. 1711–1719, 2014. View at Publisher · View at Google Scholar · View at Scopus
  106. Y. Mukai, C.-Y. Wang, Y. Rikitake, and J. K. Liao, “Phosphatidylinositol 3-kinase/protein kinase Akt negatively regulates plasminogen activator inhibitor type 1 expression in vascular endothelial cells,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 292, no. 4, pp. H1937–H1942, 2007. View at Publisher · View at Google Scholar · View at Scopus
  107. J. Partridge, H. Carlsen, K. Enesa et al., “Laminar shear stress acts as a switch to regulate divergent functions of NF-κB in endothelial cells,” The FASEB Journal, vol. 21, no. 13, pp. 3553–3561, 2007. View at Publisher · View at Google Scholar · View at Scopus
  108. X. Ling, J.-F. Ye, and X.-X. Zheng, “Dynamic investigation of leukocyte-endothelial cell adhesion interaction under fluid shear stress in vitro,” Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao, vol. 35, no. 6, pp. 567–572, 2003. View at Google Scholar · View at Scopus
  109. L. J. Taite, M. L. Rowland, K. A. Ruffino, B. R. E. Smith, M. B. Lawrence, and J. L. West, “Bioactive hydrogel substrates: probing leukocyte receptor–ligand interactions in parallel plate flow chamber studies,” Annals of Biomedical Engineering, vol. 34, no. 11, pp. 1705–1711, 2006. View at Publisher · View at Google Scholar · View at Scopus
  110. T. R. Dunkern, M. Paulitschke, R. Meyer et al., “A novel perfusion system for the endothelialisation of PTFE grafts under defined flow,” European Journal of Vascular and Endovascular Surgery, vol. 18, no. 2, pp. 105–110, 1999. View at Publisher · View at Google Scholar · View at Scopus
  111. A. Rademacher, M. Paulitschke, R. Meyer, and R. Hetzer, “Endothelialization of PTFE vascular grafts under flow induces significant cell changes,” International Journal of Artificial Organs, vol. 24, no. 4, pp. 235–242, 2001. View at Google Scholar · View at Scopus
  112. A. Neubert, K. Sternberg, S. Nagel et al., “Development of a vessel-simulating flow-through cell method for the in vitro evaluation of release and distribution from drug-eluting stents,” Journal of Controlled Release, vol. 130, no. 1, pp. 2–8, 2008. View at Publisher · View at Google Scholar · View at Scopus
  113. A. Seidlitz, S. Nagel, B. Semmling et al., “Examination of drug release and distribution from drug-eluting stents with a vessel-simulating flow-through cell,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 78, no. 1, pp. 36–48, 2011. View at Publisher · View at Google Scholar · View at Scopus
  114. K. R. Kamath, J. J. Barry, and K. M. Miller, “The Taxus drug-eluting stent: a new paradigm in controlled drug delivery,” Advanced Drug Delivery Reviews, vol. 58, no. 3, pp. 412–436, 2006. View at Publisher · View at Google Scholar · View at Scopus
  115. M. E. McCormick, R. Goel, D. Fulton, S. Oess, D. Newman, and E. Tzima, “Platelet-endothelial cell adhesion molecule-1 regulates endothelial NO synthase activity and localization through signal transducers and activators of transcription 3-dependent NOSTRIN expression,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 3, pp. 643–649, 2011. View at Publisher · View at Google Scholar · View at Scopus
  116. G. Nakazawa, J. F. Granada, C. L. Alviar et al., “Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization,” JACC: Cardiovascular Interventions, vol. 3, no. 1, pp. 68–75, 2010. View at Publisher · View at Google Scholar · View at Scopus
  117. A. Simon, T. Cohen-Bouhacina, M. C. Porté et al., “Characterization of dynamic cellular adhesion of osteoblasts using atomic force microscopy,” Cytometry A, vol. 54, no. 1, pp. 36–47, 2003. View at Google Scholar · View at Scopus
  118. E. Takai, K. D. Costa, A. Shaheen, C. T. Hung, and X. E. Guo, “Osteoblast elastic modulus measured by atomic force microscopy is substrate dependent,” Annals of Biomedical Engineering, vol. 33, no. 7, pp. 963–971, 2005. View at Publisher · View at Google Scholar · View at Scopus
  119. J. Goldman, “A brief resume of clinical observations in the treatment of superficial burns, trigeminal neuralgia, acute bursitis, and acute musculo-skeletal trauma with dimethyl sulfoxide,” Annals of the New York Academy of Sciences, vol. 141, no. 1, pp. 653–654, 1967. View at Publisher · View at Google Scholar · View at Scopus
  120. M. B. Lawrence, “In vitro flow models of leukocyte adhesion,” in Physiology of Inflammation, K. Ley, Ed., Oxford University Press, New York, NY, USA, 2001. View at Google Scholar
  121. X. Chang and M. Gorbet, “The effect of shear on in vitro platelet and leukocyte material-induced activation,” Journal of Biomaterials Applications, vol. 28, no. 3, pp. 407–415, 2013. View at Publisher · View at Google Scholar · View at Scopus
  122. M. M. M. Bilek, D. V. Bax, A. Kondyurin et al., “Free radical functionalization of surfaces to prevent adverse responses to biomedical devices,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 35, pp. 14405–14410, 2011. View at Publisher · View at Google Scholar · View at Scopus
  123. G. V. R. Born, “Aggregation of blood platelets by adenosine diphosphate and its reversal,” Nature, vol. 194, no. 4832, pp. 927–929, 1962. View at Publisher · View at Google Scholar · View at Scopus